$ 56.01
Key Takeaways
Risk factor
High price volatility
Profitability factor
Greatly overvalued vs peers
About
Hinge Health, Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. It also provides various administrative and operations support services. The company was founded in 2012 and is headquartered in San Francisco, California.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E.
Target Price
The average target price of HNGE is 63 and suggests 13% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation su
